# MIBG Scintigraphy and Strain Echocardiography in the Detection of Subclinical Cardiovascular Effects One Year After (Neo)Adjuvant Breast Cancer Treatment With Docetaxel, Doxorubicin and Cyclophosphamide (TAC): a Pilot Study

> **NCT01246856** · — · UNKNOWN · sponsor: **Radboud University Medical Center** · enrollment: 150 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01246856
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-11
- **Primary completion:** 2011-10
- **Final completion:** —
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2011-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01246856

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01246856, "MIBG Scintigraphy and Strain Echocardiography in the Detection of Subclinical Cardiovascular Effects One Year After (Neo)Adjuvant Breast Cancer Treatment With Docetaxel, Doxorubicin and Cyclophosphamide (TAC): a Pilot Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01246856. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*